22
Participants
Start Date
August 5, 2020
Primary Completion Date
October 25, 2023
Study Completion Date
April 5, 2024
CC-90009
Injection
Venetoclax
Tablet
Azacitidine
Injection
Gilteritinib
Tablet
Local Institution - UNK3, Yvoir
Local Institution - 402, Marseille
Local Institution - 404, Toulouse
Local Institution - 401, Pessac
Local Institution - 101, St Louis
Local Institution - 104, San Francisco
Local Institution - 107, New Haven
Local Institution - 103, Boston
Local Institution - 108, Hackensack
Local Institution - 105, Houston
Local Institution - 102, Seattle
Local Institution - 202, Edmonton
Local Institution - 201, Toronto
Local Institution - 301, Oxford